Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

GLP-1 drug Victoza (liraglutide), and if it can get a cardiovascular outcomes claim on its label it will shore up the product’s competitive profile. ... The near-term question for Lilly now is whether Trulicity matches Victoza’s efficacy.

Daily Brief: Blincyto another option in ALL alongside Kymriah, AZ approval for Bydureon

Daily Brief: Blincyto another option in ALL alongside Kymriah, AZ approval for Bydureon Nordisk’s Victoza and Lilly’s Trulicity, and Novo Nordisk's new arrival, Ozempic.

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Meanwhile, sales of Novo Nordisk’s top-selling drug Victoza (liraglutide) rose 2% to 11.7bn krone, mainly on volume growth in North America, while obesity spin-off brand Saxenda advanced

News: Charity criticises NHS England and Vertex over Orkambi access, Sema scores again, NodThera launched

News: Charity criticises NHS England and Vertex over Orkambi access, Sema scores again, NodThera launched One key battleground in the sector is between GLP-1 drugs, with Lilly’s Trulicity looking to challenge Novo Nordisk’s market leader Victoza – but Novo is sweeping all before it ... Victoza. Oral semaglutide also outperformed Boehringer Ingelheim

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics